These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6146608)
1. Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme. Gorman JJ; Folk JE J Biol Chem; 1984 Jul; 259(14):9007-10. PubMed ID: 6146608 [TBL] [Abstract][Full Text] [Related]
2. Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme toward synthetic peptides. Gorman JJ; Folk JE J Biol Chem; 1981 Mar; 256(6):2712-5. PubMed ID: 6110660 [TBL] [Abstract][Full Text] [Related]
3. Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII). Gorman JJ; Folk JE J Biol Chem; 1980 Jan; 255(2):419-27. PubMed ID: 6101325 [TBL] [Abstract][Full Text] [Related]
4. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate. Jeleńska MM; Fesüs L; Kopeć M Biochim Biophys Acta; 1980 Dec; 616(2):167-78. PubMed ID: 6111338 [TBL] [Abstract][Full Text] [Related]
5. Addressing substrate glutamine requirements for tissue transglutaminase using substance P analogues. Pastor MT; Diez A; Pérez-Payá E; Abad C FEBS Lett; 1999 May; 451(3):231-4. PubMed ID: 10371195 [TBL] [Abstract][Full Text] [Related]
6. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking. Achyuthan KE; Dobson JV; Greenberg CS Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839 [TBL] [Abstract][Full Text] [Related]
7. Transamidating activities of factor XIIIa and of transglutaminases, measured by an ELISA procedure. Velasco PT; Karush F; Lorand L Biochem Biophys Res Commun; 1988 Apr; 152(2):505-11. PubMed ID: 2896499 [TBL] [Abstract][Full Text] [Related]
8. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA. Sugimura Y; Hosono M; Wada F; Yoshimura T; Maki M; Hitomi K J Biol Chem; 2006 Jun; 281(26):17699-706. PubMed ID: 16636049 [TBL] [Abstract][Full Text] [Related]
9. Enzymatic and kinetic properties of blood coagulation factor XIIIa and guinea pig liver transglutaminase utilizing (6-[N-(4-aminobutyl)-N-ethylamino]-2,3-dihydrophthalazine-1,4-dione, as a novel, specific and sensitive chemiluminescent substrate. Achyuthan KE J Biolumin Chemilumin; 1998; 13(1):1-11. PubMed ID: 9608360 [TBL] [Abstract][Full Text] [Related]
10. Stereochemical aspects of amine substrate attachment to acyl intermediates of transglutaminases. Human blood plasma enzyme (activated coagulation factor XIII) and guinea pig liver enzyme. Schrode J; Folk JE J Biol Chem; 1979 Feb; 254(3):653-61. PubMed ID: 33172 [No Abstract] [Full Text] [Related]
11. New colored and fluorescent amine substrates for activated fibrin stabilizing factor (Factor XIIIa) and for transglutaminase. Lorand L; Parameswaran KN; Velasco PT; Hsu LK; Siefring GE Anal Biochem; 1983 Jun; 131(2):419-25. PubMed ID: 6193738 [TBL] [Abstract][Full Text] [Related]
12. Osteopontin, a substrate for transglutaminase and factor XIII activity. Prince CW; Dickie D; Krumdieck CL Biochem Biophys Res Commun; 1991 Jun; 177(3):1205-10. PubMed ID: 1676261 [TBL] [Abstract][Full Text] [Related]
13. Comparison of substrate specificities of transglutaminases using synthetic peptides as acyl donors. Ohtsuka T; Ota M; Nio N; Motoki M Biosci Biotechnol Biochem; 2000 Dec; 64(12):2608-13. PubMed ID: 11210124 [TBL] [Abstract][Full Text] [Related]
14. Expression of guinea-pig liver transglutaminase cDNA in Escherichia coli. Amino-terminal N alpha-acetyl group is not essential for catalytic function of transglutaminase. Ikura K; Tsuchiya Y; Sasaki R; Chiba H Eur J Biochem; 1990 Feb; 187(3):705-11. PubMed ID: 1968007 [TBL] [Abstract][Full Text] [Related]
16. Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate. Studies on kinetics of inhibition and binding of XIIIA by a cross-reacting antifibrinogen antibody. Mitkevich OV; Shainoff JR; DiBello PM; Yee VC; Teller DC; Smejkal GB; Bishop PD; Kolotushkina IS; Fickenscher K; Samokhin GP J Biol Chem; 1998 Jun; 273(23):14387-91. PubMed ID: 9603949 [TBL] [Abstract][Full Text] [Related]
17. Determination of amino- and carboxyl-terminal sequences of guinea pig liver transglutaminase: evidence for amino-terminal processing. Ikura K; Yokota H; Sasaki R; Chiba H Biochemistry; 1989 Mar; 28(5):2344-8. PubMed ID: 2566328 [TBL] [Abstract][Full Text] [Related]
18. Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation. Folk JE Adv Enzymol Relat Areas Mol Biol; 1983; 54():1-56. PubMed ID: 6133417 [No Abstract] [Full Text] [Related]
19. Amino acid sequence of guinea pig liver transglutaminase from its cDNA sequence. Ikura K; Nasu T; Yokota H; Tsuchiya Y; Sasaki R; Chiba H Biochemistry; 1988 Apr; 27(8):2898-905. PubMed ID: 2900023 [TBL] [Abstract][Full Text] [Related]
20. Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta. Takahashi N; Takahashi Y; Putnam FW Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8019-23. PubMed ID: 2877456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]